Jane Street’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Jane Street’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,556	Closed	-$69K	–	4925
2016 Q2	$69K	Buy	+15,556	New	+$34.7K	﹤0.01%	3937
2014 Q4	–	Sell	-1,853	Closed	-$21K	–	3411
2014 Q3	$21K	Sell	1,853 -1,598	-46%	-$17.8K	﹤0.01%	2465
2014 Q2	$35K	Buy	+3,451	New	+$38.1K	﹤0.01%	2454

Other funds holding BSPM

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street's BSPM Position: Q3 2016 in Review

Jane Street sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2016, closing a stake of 15,556 shares — an estimated $69K sold.

Jane Street first reported a position in BSPM in Q2 2014 and held it in 3 quarters. The position peaked at $69K in Q2 2016. 8 funds tracked by Wall St. Rank hold BSPM as of Q3 2016.

Jane Street reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Jane Street sold 15,556 Biostar Pharmaceuticals, Inc. shares in Q3 2016, an estimated $69K.
Jane Street first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
Jane Street's Biostar Pharmaceuticals, Inc. position peaked at $69K in Q2 2016.
8 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.